To describe the prevalence, severity and nature of depression in a sample of prostate cancer (PCa) survivors 10聽years after diagnosis and treatment, 146 Australian patients from the RADAR trial who received their diagnosis 10聽years previously completed the Zung Self-rating Depression Scale and a ...
Cancer that has spread beyond the prostate (such as to the bones, lymph nodes, andlungs) is not curable, but it may be controlled for many years. Because of the many advances in treatments, most men whose prostate cancer becomes widespread can expect to live 5 years or more. Some men ...
The ZERO Prostate Cancer Support Community connects patients, families, friends and caregivers to enhance the quality of life for all those affected by prostate cancer. This community is sponsored by ZERO Prostate Cancer, an Inspire trusted partner.
The 10-year relative survival rate is 98%. Ten years after their prostate cancer diagnosis, they're only 2% less likely to be alive than anyone else. The relative 15-year survival rate is 95%. The average person with prostate cancer is 5% less likely to still be living than someone who...
(McIntosh et al., 2009). NICE recommend that prostate cancer patients should have their PSA checked at least every 6 months for the first 2 years, and then at least once a year after that (NICE, 2019) but do not specify exactly when re-referral to their specialist teams should be take...
cancer mortality at a median of 10 years of follow-up. Secondary outcomes included the rates of disease progression, metastases, and all-cause deaths.RESULTSThere were 17 prostate-cancer–specific deaths overall: 8 in the active-monitoring group (1.5 deaths per 1000 person-years; 95% confidence...
expected to live longer with treatment or perceived their diagnosis of low-risk cancer was more serious. Almost three-quarters of patients who chose immediate treatment expected to live at least five years longer than they otherwise would without treatment, which is unrealistic andnot based on exist...
Genomic Prediction of 16 Complex Disease Risks Including Heart Attack, Diabetes, Breast and Prostate Cancer Louis Lello, Timothy G. Raben, Soke Yuen Yong, Laurent C. A. M. Tellier & Stephen D. H. Hsu Scientific Reports volume 9, Article number: 15286 (2019) Cite this article 13...
1.4. Metastatic Prostate Cancer’s Therapy Unfortunately, in 20–30% of cases, the tumor goes toward progression even with hematic testosterone level below 20 ng/dL [2] and become castration-resistant PCa (CRPCa). Researchers demonstrated that the resistance to ADT occurs after approximately 10–...
Among prostate cancer (PC) patients treated radically (radical prostatectomy RP or prostatic external radiotherapy RT), 27 to 53% will develop a biological recurrence (BR) [1]. BR after RP is defined as a rise in prostate-specific antigen (PSA) ≥ 0.2 ng/mL confirmed by two successive samp...